Strategy for FDA Approval of Lung Cancer Immunotherapy

Batu Biologics Strategy for FDA Approval of Lung Cancer Immunotherapy Featured in San Diego Business Journal

The donation-based crowdfunding campaign provides non-dilutive capital to the company which accelerates our ongoing preclinical lung cancer immunological experiments needed for FDA IND submission.

Read the full article at businesswire.com